Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_assertion type Assertion NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_head.
- NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_assertion description "[The use of the Continuous Performance Test (CPT), as an endophenotypic measure, is valuable for genetic studies because it may show increased sensitivity to specific dimensions in attention deficit hyperactivity disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_provenance.
- NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_assertion evidence source_evidence_literature NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_provenance.
- NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_assertion SIO_000772 14584093 NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_provenance.
- NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_assertion wasDerivedFrom befree-20140225 NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_provenance.
- NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_assertion wasGeneratedBy ECO_0000203 NP856858.RAu1wOZ9pZ_WpLT_RH-L8k0FP2LakKHmGo-iqjR55e2Fo130_provenance.